Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB25FQRP1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,626
Award facts
- Contract value 100% obligated
- $4,625.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On June 3, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,625.70 to DMS Pharmaceutical Group Inc. for the supply of Botox 100 unit vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location with an ultimate completion date of June 25, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the DLA for diverse pharmaceutical products including prescription medications, biologics, vaccines, and medical consumables. The company's qualification as a woman-owned small business has enabled it to compete effectively in federal procurement markets while leveraging its established position as a pharmaceutical wholesaler serving military and federal healthcare systems. This particular delivery order for Botox represents a routine procurement under the larger IDC framework that facilitates efficient sourcing of medical supplies to support DoD healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FQRP1?
SPE2DB25FQRP1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 3, 2025.
How much is contract SPE2DB25FQRP1 worth?
The government has obligated $4,626 on SPE2DB25FQRP1.
Is contract SPE2DB25FQRP1 an order under another contract?
Yes. SPE2DB25FQRP1 is a delivery order under SPE2DB20D9201, an indefinite delivery contract.
Was contract SPE2DB25FQRP1 competed?
The extent of competition for SPE2DB25FQRP1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award